Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Joint Development Agreement

15 Apr 2008 10:47

Oxford Advanced Surfaces Group PLC15 April 2008 15 April 2008 Oxford Advanced Surfaces Group plc ("OASG" or the "Group") Joint Development Agreement with DuPont Advanced Fiber Systems Oxford Advanced Surfaces Group plc, has entered into a Joint DevelopmentAgreement ("JDA") with DuPont Advanced Fiber Systems. The objective of the JDA is for OASG and DuPont Advanced Fiber Systems tocooperate in the development of products and processes using OASG's Onto(R)technology and with various DuPont technologies. OASG will continue to scale up its laboratories and technical staff to betterserve its increasing customer base. This JDA is a significant addition to thecompany's existing portfolio, which is currently working on projects as diverseas flat screen displays, printed circuit boards and detergents. Marcelo Bravo, Chief Executive of Oxford Advances Surfaces Group, said: "We are very excited to be working with a market leader such as DuPont AdvancedFiber Systems in the development of new materials that will provide us withexcellent opportunities to implement Onto(R) and create value for our customersthrough the delivery of new and innovative products to market." Dr. Warren F. Knoff, DuPont Fellow, DuPont Advanced Fiber Systems said: "We are delighted to be working with Oxford Surfaces and Onto(R). Through thedevelopment and application of this technology to our products we hope todeliver expanded offerings and services to our markets." Contacts Marcelo Bravo, CEO +44 (0) 1865 854 807 Oxford Advanced Surfaces Group PLC Website: www.oxfordsurfaces.com Jonathan Evans / David Galan +44 (0) 207 060 1760 Zimmerman Adams International Ltd Notes to Editors Oxford Advanced Surfaces Group plc Oxford Advanced Surfaces Group plc develops and commercialises advancedmaterials and technology solutions leveraging breakthrough surface modificationtechnology. Onto(R) is a proprietary coating technology that exploits a reactive type ofmolecule so that it can be conveniently and safely applied to a wide range ofmaterials allowing the rapid and convenient modification of the surfaceproperties. This delivers permanent, dramatic and highly valuable changes tosurface functionality. The Onto(R) coating technology is a versatile, effective,yet simple approach to deliver intelligent advanced materials. Initial applications include tailored wetting properties, adhesion,metallization and bio-activity in markets including electronics, advancedcomposites and laminates, biomaterials and alternative energy technologies. Thecompany develops and commercialises advanced materials and technology solutionsacross a range of markets including: • Electronics (PCB's, plastic electronics, electromechanical devices and flat screen displays); • Industrial specialties (specialty fibres, textiles, laminates and composites); • Life sciences / health care markets (including sterile surfaces, separation media and microarrays, biomedical materials), and; • Alternative energy technologies (photovoltaics, solid state lighting, fuel cells) Website: www.oxfordsurfaces.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jan 20228:50 amRNSHolding(s) in Company
24th Jan 20227:00 amRNSHolding(s) in Company
20th Jan 202212:15 pmRNSResult of General Meeting
20th Jan 20227:00 amRNSResult of Open Offer - Correction
19th Jan 202211:30 amRNSResult of Open Offer
4th Jan 20221:30 pmRNSPosting of Circular and Notice of GM
29th Dec 20214:36 pmRNSPrice Monitoring Extension
24th Dec 20217:00 amRNSPlacing, Subscription and Open Offer
17th Dec 20215:00 pmRNSBusiness Update and Financing
22nd Oct 20217:00 amRNSAppointment of new Scientific Advisory Board
21st Oct 20218:00 amRNSDigitalGlassware® platform trial with Aurigene
28th Sep 20217:00 amRNSCollaboration
22nd Sep 20217:00 amRNSHalf Year Results
14th Sep 202110:30 amRNSNotice of Half Year Results
8th Sep 20211:30 pmRNSHolding(s) in Company
18th Aug 20217:00 amRNSAdvisory Board Appointment
5th Aug 20217:00 amRNSCollaboration with the University of Cambridge
12th Jul 20217:00 amRNSAppointment of Non-Executive Director
30th Jun 20213:34 pmRNSResult of AGM
22nd Jun 20217:00 amRNSChanges to 2021 AGM Arrangements
17th Jun 20217:00 amRNSCollaboration with the University of Leeds
8th Jun 20213:16 pmRNSPosting of ARA and Updated Notice of AGM
1st Jun 20217:00 amRNSFinal Results
24th May 20217:00 amRNSNotice of Results and Investor Presentation
6th May 20213:43 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSCollaboration with the University of Nottingham
11th Mar 20217:00 amRNSCo-distribution agreement with Elemental Machines
9th Mar 20217:00 amRNSDirectorate Change
20th Jan 20217:00 amRNSAgreement with Merck's Life Sciences business
19th Jan 20217:00 amRNSHolding(s) in Company
8th Jan 20212:00 pmRNSPrice Monitoring Extension
18th Dec 202010:30 amRNSGrant of PDMR Options
17th Dec 20207:00 amRNSMulti-year contract with Thieme Chemistry
26th Oct 202011:05 amRNSSecond Price Monitoring Extn
26th Oct 202011:00 amRNSPrice Monitoring Extension
21st Oct 20207:00 amRNSIssue of Shares and Total Voting Rights
19th Oct 20207:00 amRNSDirectorate Changes
16th Oct 20207:00 amRNSStrong adoption of ICSYNTH
2nd Oct 20202:05 pmRNSSecond Price Monitoring Extn
2nd Oct 20202:00 pmRNSPrice Monitoring Extension
1st Oct 20208:00 amRNSGrant of Options
29th Sep 20207:00 amRNSHolding(s) in Company
23rd Sep 20201:40 pmRNSHolding(s) in Company
22nd Sep 20204:29 pmRNSHolding(s) in Company
22nd Sep 20204:00 pmRNSHolding(s) in Company
22nd Sep 202010:32 amRNSHolding(s) in Company
15th Sep 20208:08 amRNSIssue of Shares and Total Voting Rights
10th Sep 20207:00 amRNSHalf-year Report
4th Sep 20208:26 amRNSHolding(s) in Company
3rd Sep 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.